📣 Help Shape the Future of UKRI's Gateway to Research (GtR)

We're improving UKRI's Gateway to Research and are seeking your input! If you would be interested in being interviewed about the improvements we're making and to have your say about how we can make GtR more user-friendly, impactful, and effective for the Research and Innovation community, please email gateway@ukri.org.

Transcriptional reprogramming by mutated IRF4 in lymphoma. (2023)

First Author: Schleussner N

Attributed to: Finding therapeutic targets in FLT3-ITD AML using a systems biology approach funded by MRC

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.1038/s41467-023-41954-8

PubMed Identifier: 37935654

Publication URI: http://europepmc.org/abstract/MED/37935654

Type: Journal Article/Review

Volume: 14

Parent Publication: Nature communications

Issue: 1

ISSN: 2041-1723